medigraphic.com

2010, Number 4

<< Back Next >>

Enf Infec Microbiol 2010; 30 (4)

Epidemiologic characteristics of nosocomial infections. CIREN 2009

Padrón SA, Valdés FMV, Valdés FF, Rodríguez GM

Language: Spanish
References: 12
Page: 123-128
PDF size: 90.34 Kb.


ABSTRACT

Nosocomial infections are a problem among health institutions and are considered as indicators of quality attention. An analytical study was made by the Comité de Prevención de Infecciones Intrahospitalarias (CPIIH) of the Centro Internacional de Restauración Neurológica (CIREN). All septic episodes at the CIREN occurred in 2009 were included. Prevalence rate of nosocomial infections was 4.1%; major frequency was observed in the Neuropediatric Clinic; respiratory tract infections were the most frequent, and urinary tract infections represented the second cause. It was a decreased use of microbiology tests. Antibiotic prescription was given in 36.9% of hospitalized patients.


REFERENCES

  1. Bennett JV. Infecciones hospitalarias. La Habana: Ed. Científico-Técnica. 1982: 5-10.

  2. Bruin-Buisson C. “Les infections dans les hopitaux”. La Re-cherche 1994; 266: 706-707.

  3. Nodarse RH. “Visión actualizada de las infecciones intrahos-pitalarias”. Rev Cubana Med Mil 2002; 31 (3): 201-8.

  4. Gálvez R. Infección hospitalaria. Granada Universidad; 1993: 10-15.

  5. Fridkin SK, Welbel SF, Weinstein RA. “Magnitude and preven-tion of nosocomial infection in the intensive care unit”. Infect Dis Clin North Am 1997;11 (2): 479-96.

  6. MINSAP. Programa Nacional de Prevención y Control de Infec-ciones Hospitalarias. La Habana: Folleto, 1998: 1-15.

  7. Gardner JS, Jarvis WR, Grace Emori T, Horan TC, Hughes JM. “CDC definitions for nosocomial infections, 1998. Am J Infect Control” 1988; 16 (3): 128-40.

  8. Howard B. Clinical and pathogenic microbiology. 2 ed. St. Louis. Mosby, 1994: 105.

  9. OPS. La garantía de la calidad. El control de infecciones hospitalarias. HSD/SILOS-12, mayo 1991: 124-39.

  10. Chaix et al., “1999. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an Intensive Care Unit”. JAMA 28: 1745-1751.

  11. Cooper, et al., 2004. Methicillin-resistant “Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes”. Proc. Nat. Aca. Sci. USA 27: 10223-10228.

  12. McHugh and Riley, “2004. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections”. Infect. Control Hosp. Epidemiol, 25 (5): 425-430.




2020     |     www.medigraphic.com